‹ ›
MYP_027513
← PREVIOUS NEXT → BACK
Basic Information
tetrapeptide
Anticancer
Standard
4 amino acids
C25H40N8O6
Standard
Sequence
RLNF
Physicochemical Analysis
548.63 Da
9.75
0.76
0.56
0.1900
-0.35
0.35
-0.27
-30.07
97.50
0.2500
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
255.61
-1.72
9.0
7.0
17.0
39.0
1.0
4.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0055456 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Source entry describes small-molecule/peptide conjugation at one terminus; exact terminus not explicitly assigned in source metadata
Conjugate type: amide; Conjugated small molecule: 5-Chloro-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid
Bio-Activity Profile
Anticancer
PaperREPLACE: a strategy for iterative design of cyclin-binding groove inhibitors. ChemBioChem. 2006 Evidence URLhttps://doi.org/10.1002/cbic.200600189
RECORD: Rec_0071851 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Source entry describes small-molecule/peptide conjugation at one terminus; exact terminus not explicitly assigned in source metadata
Conjugate type: amide; Conjugated small molecule: 2-(1H-Pyrrol-1-yl)-6-benzothiazolecarboxylic acid
Bio-Activity Profile
Anticancer
PaperREPLACE: a strategy for iterative design of cyclin-binding groove inhibitors. ChemBioChem. 2006 Evidence URLhttps://doi.org/10.1002/cbic.200600189
RECORD: Rec_0143958 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Source entry describes small-molecule/peptide conjugation at one terminus; exact terminus not explicitly assigned in source metadata
Conjugate type: amide; Conjugated small molecule: 3-Nitro-4-(1H-1,2,4-triazol-1-yl)benzoic acid
Bio-Activity Profile
Anticancer
PaperREPLACE: a strategy for iterative design of cyclin-binding groove inhibitors. ChemBioChem. 2006 Evidence URLhttps://doi.org/10.1002/cbic.200600189
RECORD: Rec_0150192 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Source entry describes small-molecule/peptide conjugation at one terminus; exact terminus not explicitly assigned in source metadata
Conjugate type: amide; Conjugated small molecule: 1-(4-Fluorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid
Bio-Activity Profile
Anticancer
PaperREPLACE: a strategy for iterative design of cyclin-binding groove inhibitors. ChemBioChem. 2006 Evidence URLhttps://doi.org/10.1002/cbic.200600189
RECORD: Rec_0157063 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Source entry describes small-molecule/peptide conjugation at one terminus; exact terminus not explicitly assigned in source metadata
Conjugate type: amide; Conjugated small molecule: 1-(2,4-Dichloro-5-methoxyphenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid
Bio-Activity Profile
Anticancer
PaperREPLACE: a strategy for iterative design of cyclin-binding groove inhibitors. ChemBioChem. 2006 Evidence URLhttps://doi.org/10.1002/cbic.200600189
1 2 3 NEXT LAST
Showing 5 records on this page · Page 1 of 3